US 9447144
MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
granted A61KA61K2039/53A61K2239/31
Quick answer
US patent 9447144 (MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 20 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/53, A61K2239/31, A61K2239/38, A61K35/17